» Articles » PMID: 29545279

Elastase Activity on Sputum Neutrophils Correlates with Severity of Lung Disease in Cystic Fibrosis

Overview
Journal Eur Respir J
Specialty Pulmonary Medicine
Date 2018 Mar 17
PMID 29545279
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

Neutrophil elastase (NE) is a key risk factor for severity of cystic fibrosis (CF) lung disease. Recent studies identified increased NE activity on the surface of airway neutrophils from CF-like mice and patients with CF. However, the role of surface-bound NE in CF lung disease remains unknown. We determined the relationship between surface-bound NE activity and severity of lung disease in CF.Surface-bound NE activity was measured on sputum neutrophils from 35 CF patients and eight healthy controls using novel lipidated Förster resonance energy transfer reporters and correlated with free NE activity, neutrophil counts, interleukin-8, myeloperoxidase and antiproteases in sputum supernatant, and with lung function parameters.Surface-bound NE activity was increased in CF compared to healthy controls (p<0.01) and correlated with free NE activity (p<0.05) and other inflammation markers (p<0.001). Surface-bound and free NE activity correlated with forced expiratory volume in 1 s % predicted (p<0.01 and p<0.05), but only surface-bound NE activity correlated with plethysmographic functional residual capacity % pred (p<0.01) in patients with CF.We demonstrate that surface-bound NE activity on airway neutrophils correlates with severity of lung disease in patients with CF. Our results suggest that surface-bound NE activity may play an important role in the pathogenesis and serve as novel biomarker in CF lung disease.

Citing Articles

Exploring Proteases as Alternative Molecular Targets to Tackle Inflammation in Cystic Fibrosis Respiratory Infections.

Sandri A, Boschi F Int J Mol Sci. 2025; 26(5).

PMID: 40076497 PMC: 11899166. DOI: 10.3390/ijms26051871.


Inhibiting CFTR through inh-172 in primary neutrophils reveals CFTR-specific functional defects.

Da Silva Cunha A, Blanter M, Renders J, Gouwy M, Lorent N, Boon M Sci Rep. 2024; 14(1):31237.

PMID: 39732786 PMC: 11682091. DOI: 10.1038/s41598-024-82535-z.


Modulator-refractory cystic fibrosis: Defining the scope and challenges of an emerging at-risk population.

Somerville L, Borish L, Noth I, Albon D Ther Adv Respir Dis. 2024; 18:17534666241297877.

PMID: 39543951 PMC: 11565698. DOI: 10.1177/17534666241297877.


Targeting neutrophil serine proteases in bronchiectasis.

Chalmers J, Mall M, Chotirmall S, ODonnell A, Flume P, Hasegawa N Eur Respir J. 2024; 65(1).

PMID: 39467608 PMC: 11694565. DOI: 10.1183/13993003.01050-2024.


The bacterial serine protease inhibitor ecotin inhibits neutrophil elastase enzymatic activity in cystic fibrosis sputa.

Fantone K, Nothaft H, Son Y, Stecenko A, Szymanski C, Rada B Heliyon. 2024; 10(19):e38895.

PMID: 39444402 PMC: 11497391. DOI: 10.1016/j.heliyon.2024.e38895.